薬剤比較
Insulin Regular Human vs Repaglinide
Compare regular insulin vs repaglinide for type 2 diabetes. Insulin is injectable short-acting, repaglinide is oral meglitinide stimulating insulin release.
このページには比較できる項目がありません。
臨床的背景
This comparison arises for type 2 diabetes patients considering meglitinide therapy versus starting insulin.
結論
Insulin is more versatile and preferred for broader use while repaglinide offers convenient oral dosing with meal-related action.
すべての薬剤比較